-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades Amicus Therapeutics to Hold

Benzinga·12/19/2025 16:17:28
Listen to the news
Needham analyst Gil Blum downgrades Amicus Therapeutics (NASDAQ:FOLD) from Buy to Hold.